Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2005 2
2006 1
2007 1
2008 1
2009 1
2010 4
2011 5
2012 1
2013 3
2014 2
2016 3
2017 5
2018 3
2019 5
2020 5
2021 4
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
Wells DK, van Buuren MM, Dang KK, Hubbard-Lucey VM, Sheehan KCF, Campbell KM, Lamb A, Ward JP, Sidney J, Blazquez AB, Rech AJ, Zaretsky JM, Comin-Anduix B, Ng AHC, Chour W, Yu TV, Rizvi H, Chen JM, Manning P, Steiner GM, Doan XC; Tumor Neoantigen Selection Alliance; Merghoub T, Guinney J, Kolom A, Selinsky C, Ribas A, Hellmann MD, Hacohen N, Sette A, Heath JR, Bhardwaj N, Ramsdell F, Schreiber RD, Schumacher TN, Kvistborg P, Defranoux NA. Wells DK, et al. Cell. 2020 Oct 29;183(3):818-834.e13. doi: 10.1016/j.cell.2020.09.015. Epub 2020 Oct 9. Cell. 2020. PMID: 33038342 Free PMC article.
Sorafenib: a clinical and pharmacologic review.
Iyer R, Fetterly G, Lugade A, Thanavala Y. Iyer R, et al. Among authors: lugade a. Expert Opin Pharmacother. 2010 Aug;11(11):1943-55. doi: 10.1517/14656566.2010.496453. Expert Opin Pharmacother. 2010. PMID: 20586710 Review.
Circulating CD14+ HLA-DRlo/- monocytic cells as a biomarker for epithelial ovarian cancer progression.
Stenzel AE, Abrams SI, Joseph JM, Goode EL, Tario JD Jr, Wallace PK, Kaur D, Adamson AK, Buas MF, Lugade AA, Laslavic A, Taylor SE, Orr B, Edwards RP, Elishaev E, Odunsi K, Mongiovi JM, Etter JL, Winham SJ, Kaufmann SH, Modugno F, Moysich KB. Stenzel AE, et al. Among authors: lugade aa. Am J Reprod Immunol. 2021 Mar;85(3):e13343. doi: 10.1111/aji.13343. Epub 2020 Sep 21. Am J Reprod Immunol. 2021. PMID: 32905653 Free PMC article.
Murine model of chronic respiratory inflammation.
Lugade AA, Bogner PN, Thanavala Y. Lugade AA, et al. Adv Exp Med Biol. 2011;780:125-41. doi: 10.1007/978-1-4419-5632-3_11. Adv Exp Med Biol. 2011. PMID: 21842370 Review.
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer.
McGray AJR, Eppolito C, Miliotto A, Singel KL, Stephenson K, Lugade A, Segal BH, Keler T, Webster G, Lichty B, Kozbor D, Odunsi K. McGray AJR, et al. Among authors: lugade a. Cancer Immunol Immunother. 2021 Dec;70(12):3451-3460. doi: 10.1007/s00262-021-02936-1. Epub 2021 Apr 20. Cancer Immunol Immunother. 2021. PMID: 33880648 Free PMC article.
Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers.
Zhu Q, Wang J, Yu H, Hu Q, Bateman NW, Long M, Rosario S, Schultz E, Dalgard CL, Wilkerson MD, Sukumar G, Huang RY, Kaur J, Lele SB, Zsiros E, Villella J, Lugade A, Moysich K, Conrads TP, Maxwell GL, Odunsi K. Zhu Q, et al. Among authors: lugade a. Cancers (Basel). 2022 May 10;14(10):2350. doi: 10.3390/cancers14102350. Cancers (Basel). 2022. PMID: 35625955 Free PMC article.
Nature of tumour rejection antigens in ovarian cancer.
Want MY, Lugade AA, Battaglia S, Odunsi K. Want MY, et al. Among authors: lugade aa. Immunology. 2018 Oct;155(2):202-210. doi: 10.1111/imm.12951. Epub 2018 Jun 13. Immunology. 2018. PMID: 29772069 Free PMC article. Review.
47 results